BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23636926)

  • 1. Diagnostic screening identifies a wide range of mutations involving the SHOX gene, including a common 47.5 kb deletion 160 kb downstream with a variable phenotypic effect.
    Bunyan DJ; Baker KR; Harvey JF; Thomas NS
    Am J Med Genet A; 2013 Jun; 161A(6):1329-38. PubMed ID: 23636926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mosaic compound heterozygosity of SHOX resulting in Leri-Weill dyschondrosteosis with marked short stature: implications for disease mechanisms and recurrence risks.
    Reish O; Huber C; Altarescu G; Chapman-Shimshoni D; Levy-Lahad E; Renbaum P; Mashevich M; Munnich A; Cormier-Daire V
    Am J Med Genet A; 2010 Sep; 152A(9):2230-5. PubMed ID: 20683993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.
    Benito-Sanz S; Thomas NS; Huber C; Gorbenko del Blanco D; Aza-Carmona M; Crolla JA; Maloney V; Rappold G; Argente J; Campos-Barros A; Cormier-Daire V; Heath KE
    Am J Hum Genet; 2005 Oct; 77(4):533-44. PubMed ID: 16175500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.
    Benito-Sanz S; Aza-Carmona M; Rodríguez-Estevez A; Rica-Etxebarria I; Gracia R; Campos-Barros A; Heath KE
    Eur J Hum Genet; 2012 Jan; 20(1):125-7. PubMed ID: 22071895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duplications upstream and downstream of SHOX identified as novel causes of Leri-Weill dyschondrosteosis or idiopathic short stature.
    Bunyan DJ; Baffico M; Capone L; Vannelli S; Iughetti L; Schmitt S; Taylor EJ; Herridge AA; Shears D; Forabosco A; Coviello DA
    Am J Med Genet A; 2016 Apr; 170A(4):949-57. PubMed ID: 26698168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAR1 deletions downstream of SHOX are the most frequent defect in a Spanish cohort of Léri-Weill dyschondrosteosis (LWD) probands.
    Benito-Sanz S; del Blanco DG; Aza-Carmona M; Magano LF; Lapunzina P; Argente J; Campos-Barros A; Heath KE
    Hum Mutat; 2006 Oct; 27(10):1062. PubMed ID: 16941489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHOX mutations in a family and a fetus with Langer mesomelic dwarfism.
    Thomas NS; Maloney V; Bass P; Mulik V; Wellesley D; Castle B
    Am J Med Genet A; 2004 Jul; 128A(2):179-84. PubMed ID: 15214013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHOX far-downstream copy-number variations involving cis-regulatory nucleotide variants in two sisters with Leri-Weill dyschondrosteosis.
    Ogushi K; Muroya K; Shima H; Jinno T; Miyado M; Fukami M
    Am J Med Genet A; 2019 Sep; 179(9):1778-1782. PubMed ID: 31228230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygosity for a novel deletion downstream of the SHOX gene provides evidence for an additional long range regulatory region with a mild phenotypic effect.
    Bunyan DJ; Taylor EJ; Maloney VK; Blyth M
    Am J Med Genet A; 2014 Nov; 164A(11):2764-8. PubMed ID: 25125269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SHOX region and its mutations.
    Capone L; Iughetti L; Sabatini S; Bacciaglia A; Forabosco A
    J Endocrinol Invest; 2010 Jun; 33(6 Suppl):11-4. PubMed ID: 21057179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of phenotypic anomalies in four families with deletion of the SHOX enhancer region.
    Gatta V; Palka C; Chiavaroli V; Franchi S; Cannataro G; Savastano M; Cotroneo AR; Chiarelli F; Mohn A; Stuppia L
    BMC Med Genet; 2014 Jul; 15():87. PubMed ID: 25056248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound heterozygous deletions in pseudoautosomal region 1 in an infant with mild manifestations of langer mesomelic dysplasia.
    Tsuchiya T; Shibata M; Numabe H; Jinno T; Nakabayashi K; Nishimura G; Nagai T; Ogata T; Fukami M
    Am J Med Genet A; 2014 Feb; 164A(2):505-10. PubMed ID: 24311385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of
    Gürsoy S; Hazan F; Aykut A; Nalbantoğlu Ö; Korkmaz HA; Demir K; Özkan B; Çoğulu Ö
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):358-365. PubMed ID: 32295321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.
    Shima H; Tanaka T; Kamimaki T; Dateki S; Muroya K; Horikawa R; Kanno J; Adachi M; Naiki Y; Tanaka H; Mabe H; Yagasaki H; Kure S; Matsubara Y; Tajima T; Kashimada K; Ishii T; Asakura Y; Fujiwara I; Soneda S; Nagasaki K; Hamajima T; Kanzaki S; Jinno T; Ogata T; Fukami M;
    J Hum Genet; 2016 Jul; 61(7):585-91. PubMed ID: 26984564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Gypsy SHOX mutation (p.A170P) in Léri-Weill dyschondrosteosis and Langer mesomelic dysplasia.
    Barca-Tierno V; Aza-Carmona M; Barroso E; Heine-Suner D; Azmanov D; Rosell J; Ezquieta B; Montané LS; Vendrell T; Cruz J; Santos F; Rodríguez JI; Pozo J; Argente J; Kalaydjieva L; Gracía R; Campos-Barros A; Benito-Sanz S; Heath KE
    Eur J Hum Genet; 2011 Dec; 19(12):1218-25. PubMed ID: 21712857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
    Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
    Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound heterozygosity of SHOX-encompassing and downstream PAR1 deletions results in Langer mesomelic dysplasia (LMD).
    Campos-Barros A; Benito-Sanz S; Ross JL; Zinn AR; Heath KE
    Am J Med Genet A; 2007 May; 143A(9):933-8. PubMed ID: 17394206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
    Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
    J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.
    Jorge AA; Souza SC; Nishi MY; Billerbeck AE; Libório DC; Kim CA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):130-5. PubMed ID: 17201812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular evaluation of SHOX/PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS).
    Benito-Sanz S; Barroso E; Heine-Suñer D; Hisado-Oliva A; Romanelli V; Rosell J; Aragones A; Caimari M; Argente J; Ross JL; Zinn AR; Gracia R; Lapunzina P; Campos-Barros A; Heath KE
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E404-12. PubMed ID: 21147883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.